Objectif The aim of the innovation project Dermtest is to develop a toolkit for general practitioners (GPs) to empower them in taking charge of patient management in melanoma prevention, detection and treatment. Melanoma is a growing form of cancer accounting for up to 3% of all cancer incidences in Europe. Problems regarding the health systems in Europe (cost-pressure, low access to specialists, long waiting times, lack of integration, weak primary care) set barriers for early detection and on-time treatment. Yet only if melanoma is detected and treated early, the chance of cure is high. GPs as the first contact for a patient can help, but currently they do not have the necessary tools to do that. We propose a toolkit for GPs, which will combine (1) teledermoscopy – remote and fast dermatologist consultation and diagnosis confirmation based on a digital image made by the GP, (2) a smart-phone app for pre-screening of moles, (3) decision support with new diagnostic hardware, (4) integrated software for good communication of patient data between the GP and other specialists (dermatologist, surgeon, pathology lab) and (5) an e-marketplace for allowing quick access to dermatologists’ opinion in different markets. By using teledermoscopy, already 700 remote consultations have been provided to GPs. The full toolkit is an innovative combination of state-of-the-art technologies ensuring fluent care provision and communication.The solution seeks to change the existing European market by shifting a greater role of melanoma prevention and treatment to the more than 450 000 GPs in the region. Empowering the GP in melanoma management would reduce waiting times for patients and increase earlier detection rates and provide on-time treatment – in the end, this means lower melanoma mortality in Europe. A feasibility study is needed, as phase 1, to help to assess the feasibility of such a disruptive approach and prioritize market penetration and development activities of the solution. Champ scientifique social sciencesmedia and communicationsgraphic designsocial sciencessociologydemographymortalitymedical and health sciencesclinical medicineoncologyskin cancermelanomasocial scienceseconomics and businessbusiness and managementbusiness modelsmedical and health sciencesbasic medicinepathology Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Appel à propositions H2020-SMEInst-2014-2015 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2014 Régime de financement SME-1 - SME instrument phase 1 Coordinateur DERMATOONKOLOOGIA KLIINIK OU Contribution nette de l'UE € 50 000,00 Adresse KOTKA 12 11315 TALLINN HARJU MAAKOND Estonie Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Eesti Eesti Põhja-Eesti Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00 Participants (1) Trier par ordre alphabétique Trier par contribution nette de l'UE Tout développer Tout réduire DERMTEST OÜ Estonie Contribution nette de l'UE € 0,00 Adresse MOISA 4 13522 Tallinn Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Eesti Eesti Põhja-Eesti Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total Aucune donnée